Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Opthea's Phase 3 COAST Trial Fails To Meet Primary Endpoint, Casting Doubt On Company's Future And Triggering Solvency Concerns

Author: Benzinga Newsdesk | March 24, 2025 01:12am
  • COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from baseline to week 52
  • Opthea considering impact of negative trial results under its Development Funding Agreement and on the Company as a going concern

Posted In: OPT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist